StonvexLoading…
StonvexStonvexStonvexCore line items from XELB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.14M | $4.94M | $3.77M | $2.65M |
Operating Income | $-1.88M | $-13.23M | $-11.28M | $-3.84M |
Net Income | $-2.49M | $-17.46M | $-14.68M | $-6.79M |
EPS (Diluted) | $-0.42 | $-5.08 | $-5.06 | $-2.84 |
Total Assets | $36.42M | $38.95M | $40.46M | $47.19M |
Total Liabilities | $23.24M | $23.12M | $23.88M | $24.69M |
Cash & Equivalents | $179.00K | $1.15M | $1.49M | $970.00K |
Free Cash Flow OCF − CapEx | Not available | $-7.03M | $-5.21M | $-3.81M |
Shares Outstanding | 5.91M | 5.88M | 4.81M | 2.44M |